Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
06/2012
06/07/2012WO2012072692A2 Use of cytokine-releasing, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, in particular of osteoarthrosis
06/07/2012WO2012048446A8 New use of chemical ingredients in cynomorium as phytoestrogen
06/07/2012US20120142758 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
06/07/2012US20120142745 Novel phenyl oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142695 Compounds as bradykinin b1 antagonists
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142678 Novel compound useful for the treatment of degenerative and inflammatory diseases
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142641 Targetted drug delivery to the bone
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142628 Methods for treating crepitus
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142597 Biomolecular coating for implants
06/07/2012US20120142595 Tissue protective peptides and uses thereof
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120141596 Multi-Purpose Bio-Material Composition
06/07/2012US20120141557 Highly-mineralized osteogenic sponge compositions and uses thereof
06/07/2012US20120141555 Compound and device for treating bone and/or cartilage defects
06/07/2012US20120141547 Methods of making cell sheets, tissue sheets and tissue engineered blood vessels
06/07/2012US20120141543 Carbon Nanotube Based Nanocomposites
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141532 Botulinum Toxin Formulation
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141505 Cd19-ligand and use
06/07/2012US20120141499 Specific binding agents of human angiopoietin-2
06/07/2012US20120141492 Anti-il 17a /il-17f cross-reactive antibodies and methods of use thereof
06/07/2012US20120141475 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141474 TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141446 Oral Nutritional Supplement Delivery System
06/07/2012US20120141430 Tissue Regeneration Membrane
06/07/2012US20120141428 Muscle-derived cells (mdcs) for treating muscle- or bone-related injury or dysfunction
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141387 Composition including an unsaponifiable fraction
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012CA2819619A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/06/2012EP2460806A1 Nitrogen-containing spiro-ring compound and medicinal use of same
06/06/2012EP2460537A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/06/2012EP2460529A1 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/06/2012EP2460528A1 Therapeutic agent and therapeutic method for periodontal diseases and pulpal diseases
06/06/2012EP2460524A1 Medicinal composition for iontophoresis
06/06/2012EP2460518A1 Composition including a chondroprotective agent and vitamins
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459000A1 Flavanones-containing food compositions
06/06/2012EP2196475B1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/06/2012EP2001842B1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
06/06/2012EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
06/06/2012DE102010062288A1 Verwendung von Zytokine-freisetzenden, biodegradierbaren Partikeln in Hyaluronsäure zur Behandlung von Knorpeldefekten, insbesondere von Osteoarthrose Use of cytokine release, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, particularly osteoarthritis
06/06/2012CN1935839B Analogues of GLP-1
06/06/2012CN102485888A Effect of pulse electromagnetic field on promotion of in vitro osteogenesis and differentiation of human umbilical cord mesenchymal stem cells
06/06/2012CN102485734A Compound for increasing bone mineral density and synthetic method thereof
06/06/2012CN102485270A Traditional Chinese medicine preparation for treating gout and preparation method thereof
06/06/2012CN102485215A Etodolac timed-release pellet and preparation method thereof
06/06/2012CN102018806B Gardenin channel-relaxing powder and preparation method thereof
06/06/2012CN102000165B Traditional Chinese medicinal composition for treating fracture and preparation method thereof
06/06/2012CN101966237B Medicament for treating paralysis and preparation method thereof
06/06/2012CN101757469B Medicament for treating rheumatoid arthritis and preparation method thereof
06/06/2012CN101648008B Compound preparation used for joint care and preparation method thereof
06/06/2012CN101590109B Compound preparation for treating back pain caused by senile osteoporosis and preparation method thereof
06/06/2012CN101564496B Plaster for mainly curing periarthritis of shoulder
06/06/2012CN101511369B Methods and compositions for inhibiting angiogenesis.
06/06/2012CN101437834B Modulation of cytokine signaling regulators and applications for immunotherapy
06/05/2012US8193312 Bone morphogenic protein binding peptide
06/05/2012US8193231 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193230 Compositions comprising N3 alkylated benzimidazole derivatives as MEK inhibitors and methods of use thereof
06/05/2012US8193229 Method of treatment using N3 alkylated benzimidazole derivatives as MEK inhibitors
06/05/2012US8193199 Heterocyclic compounds and their uses
06/05/2012US8193182 Substituted isoquinolin-1(2H)-ones, and methods of use thereof
06/05/2012US8193166 Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation
06/05/2012US8192987 Human dental follicle stem cells and methods for obtaining
06/05/2012CA2557275C Bicyclo derivative
06/05/2012CA2406278C Inhibitors of human phosphatidyl-inositol 3-kinase delta
06/05/2012CA2368670C Modulation of vascular permeability by means of tie2 receptor activators
06/05/2012CA2324226C Inhibitors of caspases
05/2012
05/31/2012WO2012071184A1 Indole derivatives as modulators of s1p receptors
05/31/2012WO2012070758A2 Fusion protein for tooth and bone regeneration
05/31/2012WO2012070003A1 Hla-g isoform for use in the treatment of a disease associated with bone resorption
05/31/2012WO2012069917A1 Bicyclic gpr119 modulators
05/31/2012WO2012069402A1 Substituted cyclopentyl - azines as casr- active compounds
05/31/2012WO2012069150A2 Cytoprotectant agents for the prevention of drug-associated side-effects
05/31/2012WO2012068702A1 Benzo 5-membered unsaturated heterocyclic compounds and preparation methods thereof
1 ... 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 ... 820